{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T01:12:55Z","timestamp":1783732375422,"version":"3.55.0"},"reference-count":32,"publisher":"American Academy of Insurance Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Insur Med"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:p>Traditional cigarette smoking has declined markedly over recent decades due to increased health awareness, regulatory action, and public health campaigns. At the same time, alternative nicotine products, particularly e-cigarettes and oral nicotine pouches, have gained popularity, especially in the United States and Europe and among younger populations. While cigarettes remain the most widely used tobacco product globally, tobacco and nicotine consumption now spans a broad range of combustible and non-combustible products, with smokeless tobacco predominating in some regions.<\/jats:p>\n                  <jats:p>Definitions of a \u201csmoker\u201d vary significantly between clinical practice and insurance medicine. Clinical definitions are nuanced and health-focused, whereas insurance classifications are typically binary and time-bound, often defining a smoker as anyone who has used a nicotine-containing product within the past 12 months. The growing use of alternative nicotine products, alongside evolving cannabis legislation, has exposed limitations in traditional definitions when it comes to accurately capturing associated risk.<\/jats:p>\n                  <jats:p>The expansion of alternative nicotine products challenges traditional smoker classifications used in insurance underwriting. While combustible tobacco remains the highest risk exposure, growing evidence supports the existence of a heterogeneous medium risk group associated with nicotine, noncombustible products. Although generally lower risk than cigarettes, these products are not risk-free, particularly considering early cardiovascular and metabolic effects, dual or poly-use patterns, and growing uptake at younger ages. For insurers, this evolving landscape highlights the benefit of a more nuanced underwriting approach, including enhanced disclosure of product type and use patterns, improved verification strategies, and potential pricing differentiation that better aligns risk with exposure.<\/jats:p>","DOI":"10.17849\/insm-53-2-1-13.1","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:18:25Z","timestamp":1781608705000},"page":"135-147","source":"Crossref","is-referenced-by-count":0,"title":["The Smoking Dilemma: A Technical Deep Dive"],"prefix":"10.17849","volume":"53","author":[{"given":"Natalia","family":"Reyes-Cancino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyssa","family":"Del Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asha","family":"Sapre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Chedid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7324","reference":[{"key":"i-53-2-135-ref01","series-title":"Respir Med","first-page":"107494","article-title":"Effects of cannabis smoking on the respiratory system: A state-of-the-art review","volume":"221","author":"Khoj","year":"2024","unstructured":"Khoj L,\nZag\u00e0 V,\nAmram DL, et al. Effects of cannabis smoking on the respiratory system: A state-of-the-art review. Respir Med. 2024;221:107494."},{"key":"i-53-2-135-ref02","series-title":"Brain Sci","first-page":"97","article-title":"Exploring the Practice of Dual Vaping: Health Risks and Behavioral Patterns in Nicotine and Cannabis E-Cigarette Users","volume":"15","author":"Vaccari Bongetta","year":"2025","unstructured":"Vaccari Bongetta GN,\nFran\u00e7a RF,\nPedro MOP, et al. Exploring the Practice of Dual Vaping: Health Risks and Behavioral Patterns in Nicotine and Cannabis E-Cigarette Users. Brain Sci. 2025;15:97."},{"key":"i-53-2-135-ref03","series-title":"Pulm Ther","first-page":"395","article-title":"Cannabis and Lung Health: Does the Bad Outweigh the Good","volume":"7","author":"Kaplan","year":"2021","unstructured":"Kaplan AG. Cannabis and Lung Health: Does the Bad Outweigh the Good? Pulm Ther. 2021;7:395\u2013408."},{"key":"i-53-2-135-ref04","series-title":"Nicotine Tob Res","first-page":"635","article-title":"Cigarette Smoking Reduction and Health Risks: A Systematic Review and Meta-analysis","volume":"23","author":"Chang","year":"2021","unstructured":"Chang JT,\nAnic GM,\nRostron BL,\nTanwar M,\nChang CM. Cigarette Smoking Reduction and Health Risks: A Systematic Review and Meta-analysis. Nicotine Tob Res. 2021;23:635\u2013642."},{"key":"i-53-2-135-ref05","series-title":"BMJ","first-page":"1519","article-title":"Mortality in relation to smoking: 50 years' observations on male British doctors","volume":"328","author":"Doll","year":"2004","unstructured":"Doll R,\nPeto Richard,\nBoreham Jillian,\nSutherland Isabelle. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ. 2004;328:1519."},{"key":"i-53-2-135-ref06","series-title":"Am J Prev Med","first-page":"504","article-title":"Association of Smoking and Smoking Cessation With Overall and Cause-Specific Mortality","volume":"60","author":"Zhu","year":"2021","unstructured":"Zhu D,\nZhao G,\nWang X. Association of Smoking and Smoking Cessation With Overall and Cause-Specific Mortality. Am J Prev Med. 2021;60:504\u2013512."},{"key":"i-53-2-135-ref07","series-title":"Nicotine Tob Res","first-page":"111","article-title":"How should we define light or intermittent smoking? Does it matter","volume":"11","author":"Husten","year":"2009","unstructured":"Husten CG. How should we define light or intermittent smoking? Does it matter? Nicotine Tob Res. 2009;11:111\u2013121."},{"key":"i-53-2-135-ref08","series-title":"JAMA Intern Med","first-page":"87","article-title":"Association of Long-term, Low-Intensity Smoking With All-Cause and Cause-Specific Mortality in the National Institutes of Health-AARP Diet and Health Study","volume":"177","author":"Inoue-Choi","year":"2017","unstructured":"Inoue-Choi M,\nLiao LM,\nReyes-Guzman C,\nHartge P,\nCaporaso N,\nFreedman ND. Association of Long-term, Low-Intensity Smoking With All-Cause and Cause-Specific Mortality in the National Institutes of Health-AARP Diet and Health Study. JAMA Intern Med. 2017;177:87\u201395."},{"key":"i-53-2-135-ref09","series-title":"Int J Cardiol","first-page":"106","article-title":"Risk of all-cause mortality and cardiovascular disease associated with secondhand smoke exposure: a systematic review and meta-analysis","volume":"199","author":"Lv","year":"2015","unstructured":"Lv X,\nSun J,\nBi Y,\nXu M,\nLu J,\nZhao L,\nXu Y. Risk of all-cause mortality and cardiovascular disease associated with secondhand smoke exposure: a systematic review and meta-analysis. Int J Cardiol. 2015;199:106\u2013115."},{"key":"i-53-2-135-ref10","series-title":"BMJ","first-page":"200","article-title":"Passive smoking and risk of coronary heart disease and stroke: prospective study with cotinine measurement","volume":"329","author":"Whincup","year":"2004","unstructured":"Whincup PH,\nGilg JA,\nEmberson JR, et al. Passive smoking and risk of coronary heart disease and stroke: prospective study with cotinine measurement. BMJ. 2004;329:200\u2013205."},{"key":"i-53-2-135-ref11","series-title":"J Epidemiol Community Health","first-page":"794","article-title":"Biomarker-assessed passive smoking in relation to cause-specific mortality: pooled data from 12 prospective cohort studies comprising 36 584 individuals","volume":"75","author":"Kvaavik","year":"2021","unstructured":"Kvaavik E,\nTverdal A,\nBatty GD. Biomarker-assessed passive smoking in relation to cause-specific mortality: pooled data from 12 prospective cohort studies comprising 36 584 individuals. J Epidemiol Community Health. 2021;75:794\u2013799."},{"key":"i-53-2-135-ref12","series-title":"A Report of the Surgeon General. Department of Health and Human Services, Centers for Disease Control and Prevention","article-title":"The Health Consequences of Smoking: 50 years of progress","author":"Services USDOHAH","year":"2014","unstructured":"Services USDOHAH. The Health Consequences of Smoking: 50 years of progress. A Report of the Surgeon General. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion. Office on Smoking and Health. 2014."},{"key":"i-53-2-135-ref13","series-title":"JAMA Intern Med","first-page":"469","article-title":"Association of Cigarette, Cigar, and Pipe Use With Mortality Risk in the US Population","volume":"178","author":"Christensen","year":"2018","unstructured":"Christensen CH,\nRostron B,\nCosgrove C, et al. Association of Cigarette, Cigar, and Pipe Use With Mortality Risk in the US Population. JAMA Intern Med. 2018;178:469\u2013476."},{"key":"i-53-2-135-ref14","series-title":"J Am Coll Cardiol","first-page":"488","article-title":"CASS Registry long term surgical survival","volume":"33","author":"Myers","year":"1999","unstructured":"Myers WO,\nBlackstone EH,\nDavis K,\nFoster ED,\nKaiser GC. CASS Registry long term surgical survival. Coronary Artery Surgery Study. J Am Coll Cardiol. 1999;33:488\u2013498."},{"key":"i-53-2-135-ref15","series-title":"Global Heart","first-page":"14","article-title":"Nicotine and Cardiovascular Health: When Poison is Addictive \u2013 a WHF Policy Brief","volume":"19","author":"Dorotheo","year":"2024","unstructured":"Dorotheo EU,\nArora M,\nBanerjee A. Nicotine and Cardiovascular Health: When Poison is Addictive \u2013 a WHF Policy Brief. Global Heart. 2024;19:14."},{"key":"i-53-2-135-ref16","series-title":"Nicotine Tob Res","first-page":"767","article-title":"Nicotine Toxicity from Repeat Use of Nicotine Pouches","volume":"27","author":"Kent","year":"2025","unstructured":"Kent JT,\nMok G,\nAustin E. Nicotine Toxicity from Repeat Use of Nicotine Pouches. Nicotine Tob Res. 2025;27:767\u2013768."},{"key":"i-53-2-135-ref17","series-title":"Nicotine Tob Res","first-page":"309","article-title":"Oral Nicotine Pouch Misuse Popularized Online Raises Concerns","volume":"28","author":"Patterson","year":"2026","unstructured":"Patterson JG,\nEl-Hellani A,\nBrinkman MC,\nKeller-Hamilton B. Oral Nicotine Pouch Misuse Popularized Online Raises Concerns. Nicotine Tob Res. 2026;28:309\u2013311."},{"key":"i-53-2-135-ref18","series-title":"Toxicol Rep","first-page":"101779","article-title":"Beyond smoking: Risk assessment of nicotine in pouches","volume":"13","author":"Reimann","year":"2024","unstructured":"Reimann H,\nBerger M,\nEckert E,\nMerches K,\nB\u00f6rnke F. Beyond smoking: Risk assessment of nicotine in pouches. Toxicol Rep. 2024;13:101779."},{"key":"i-53-2-135-ref19","series-title":"Front Pharmacol","first-page":"1392027","article-title":"Small pouches, but high nicotine doses-nicotine delivery and acute effects after use of tobacco-free nicotine pouches","volume":"15","author":"Mallock-Ohnesorg","year":"2024","unstructured":"Mallock-Ohnesorg N,\nRabenstein A,\nStoll Y, et al. Small pouches, but high nicotine doses-nicotine delivery and acute effects after use of tobacco-free nicotine pouches. Front Pharmacol. 2024;15:1392027."},{"key":"i-53-2-135-ref20","series-title":"Circ Res","first-page":"1168","article-title":"Electronic Nicotine Delivery Systems and Cardiovascular\/Cardiometabolic Health","volume":"132","author":"Mears","year":"2023","unstructured":"Mears MJ,\nHookfin HL,\nBandaru P,\nVidal P,\nStanford KI,\nWold LE. Electronic Nicotine Delivery Systems and Cardiovascular\/Cardiometabolic Health. Circ Res. 2023;132:1168\u20131180."},{"key":"i-53-2-135-ref21","series-title":"Food Chem Toxicol","first-page":"114507","article-title":"Comparative systematic review on the safety of e-cigarettes and conventional cigarettes","volume":"185","author":"Yayan","year":"2024","unstructured":"Yayan J,\nFranke K-J,\nBiancosino C,\nRasche K, et al. Comparative systematic review on the safety of e-cigarettes and conventional cigarettes. Food Chem Toxicol. 2024;185:114507."},{"key":"i-53-2-135-ref22","series-title":"Br J Gen Pract","first-page":"e89","article-title":"Cannabis, tobacco smoking, and lung function: a cross-sectional observational study in a general practice population","volume":"65","author":"Macleod","year":"2015","unstructured":"Macleod J,\nRobertson R,\nCopeland L,\nMcKenzie J,\nElton R,\nReid P. Cannabis, tobacco smoking, and lung function: a cross-sectional observational study in a general practice population. Br J Gen Pract. 2015;65:e89\u2013e95."},{"key":"i-53-2-135-ref23","series-title":"JAMA Netw Open","first-page":"e184841","article-title":"Acute Effects of Smoked and Vaporized Cannabis in Healthy Adults Who Infrequently Use Cannabis: A Crossover Trial","volume":"1","author":"Spindle","year":"2018","unstructured":"Spindle TR,\nCone EJ,\nSchlienz NJ. Acute Effects of Smoked and Vaporized Cannabis in Healthy Adults Who Infrequently Use Cannabis: A Crossover Trial. JAMA Netw Open. 2018;1:e184841."},{"key":"i-53-2-135-ref24","series-title":"JAMA Otolaryngol Head Neck Surg","first-page":"1068","article-title":"Cannabis Use and Head and Neck Cancer","volume":"150","author":"Gallagher","year":"2024","unstructured":"Gallagher TJ,\nChung RS,\nLin ME,\nKim I,\nKokot NC. Cannabis Use and Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2024;150:1068\u20131075."},{"key":"i-53-2-135-ref25","series-title":"Prev Med Rep","first-page":"103185","article-title":"Cannabis use disorder and five-year risk of oral cancer in a multicenter clinical cohort","volume":"57","author":"Cuomo","year":"2025","unstructured":"Cuomo RE. Cannabis use disorder and five-year risk of oral cancer in a multicenter clinical cohort. Prev Med Rep. 2025;57:103185."},{"key":"i-53-2-135-ref26","series-title":"J Clin Med","first-page":"5620","article-title":"Cannabis Use Variations and Myocardial Infarction: A Systematic Review","volume":"13","author":"van Amsterdam","year":"2024","unstructured":"van Amsterdam J,\nvan den Brink W. Cannabis Use Variations and Myocardial Infarction: A Systematic Review. J Clin Med. 2024;13:5620."},{"key":"i-53-2-135-ref27","series-title":"Tob Control","first-page":"582","article-title":"Heat-not-burn tobacco products: a systematic literature review","volume":"28","author":"Simonavicius","year":"2019","unstructured":"Simonavicius E,\nMcNeill A,\nShahab L,\nBrose LS. Heat-not-burn tobacco products: a systematic literature review. Tob Control. 2019;28:582\u2013594."},{"key":"i-53-2-135-ref28","series-title":"Clin Biochem","first-page":"128","article-title":"Novel proposed cutoff values for anatabine and anabasine in differentiating smokers from non-smokers","volume":"116","author":"Colsoul","year":"2023","unstructured":"Colsoul ML,\nMcNeill A,\nLion Shahab L,\nBrose LS. Novel proposed cutoff values for anatabine and anabasine in differentiating smokers from non-smokers. Clin Biochem. 2023;116:128\u2013131."},{"key":"i-53-2-135-ref29","series-title":"Int J Environ Res Public Health","first-page":"9744","article-title":"Anabasine and Anatabine Exposure Attributable to Cigarette Smoking: National Health and Nutrition Examination Survey (NHANES) 2013-2014","volume":"19","author":"Bendik","year":"2022","unstructured":"Bendik PB,\nRutt SM,\nPine BN, et al. Anabasine and Anatabine Exposure Attributable to Cigarette Smoking: National Health and Nutrition Examination Survey (NHANES) 2013-2014. Int J Environ Res Public Health. 2022;19:9744."},{"key":"i-53-2-135-ref30","series-title":"Nicotine Tob Res","first-page":"573","article-title":"Tobacco-Specific Nitrosamines (NNAL, NNN, NAT, and NAB) Exposures in the US Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014)","volume":"23","author":"Xia","year":"2021","unstructured":"Xia B,\nBlount BC,\nGuillot T, et al. Tobacco-Specific Nitrosamines (NNAL, NNN, NAT, and NAB) Exposures in the US Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014). Nicotine Tob Res. 2021;23:573\u2013583."},{"key":"i-53-2-135-ref31","series-title":"Nicotine Tob Res","first-page":"1086","article-title":"Biochemical Verification of Tobacco Use and Abstinence: 2019 Update","volume":"22","author":"Benowitz","year":"2020","unstructured":"Benowitz NL,\nBernert JT,\nFoulds J, et al. Biochemical Verification of Tobacco Use and Abstinence: 2019 Update. Nicotine Tob Res. 2020;22:1086\u20131097."},{"key":"i-53-2-135-ref32","series-title":"Epigenetics","first-page":"178","article-title":"DNA methylation differentiates smoking from vaping and non-combustible tobacco use","volume":"17","author":"Andersen","year":"2022","unstructured":"Andersen A,\nReimer R,\nKelsey Dawes K, et al. DNA methylation differentiates smoking from vaping and non-combustible tobacco use. Epigenetics. 2022;17:178\u2013190."}],"container-title":["Journal of Insurance Medicine"],"original-title":[],"link":[{"URL":"https:\/\/jim.kglmeridian.com\/view\/journals\/insm\/53\/2\/article-p135.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jim.kglmeridian.com\/downloadpdf\/journals\/insm\/53\/2\/article-p135.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jim.kglmeridian.com\/downloadpdf\/journals\/insm\/53\/2\/article-p135.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:30:58Z","timestamp":1783729858000},"score":1,"resource":{"primary":{"URL":"https:\/\/jim.kglmeridian.com\/view\/journals\/insm\/53\/2\/article-p135.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":32,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.17849\/insm-53-2-1-13.1","relation":{},"ISSN":["0743-6661"],"issn-type":[{"value":"0743-6661","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}